Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. This is our last newsletter of the year! We’re taking a break but we’ll be back on Monday, Jan. 5. In the meantime, hope you all enjoy the holidays, eat lots, and sleep…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning, all! Today, we hear an optimistic view of the biotech IPO market next year, note a few key FDA issues to watch in 2026, see an interesting Trump deal that asks companies to…
Good morning, Jason Mast here filing in for Ed on this Christmas week. No coffee this morning — well, not yet — but rather some Yemeni Tea from a certain rapidly expanding New York haunt. It’s sweeter than my usual cup and warmer. Ten out of ten. Anyway, here’s some news for you today. I…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we exclusively write about how politics are shaping the new FDA voucher program, see how the U.K. might buoy U.S. science with renewed investment, and more. The need-to-know this morning BioMarin said…
Feeding babies peanut-containing foods as early as possible can help prevent peanut allergy, but a new study published in JAMA Network Open found that parents need more support to get it right. Interviews with parents revealed widespread confusion about the purpose, risks, and timing of early peanut introduction guidelines. “While some parents we talked to…
Access to autism evaluations through specialty health care is notorious for long wait times across the United States. In Missouri, many families wait nearly a year for a diagnostic appointment. AI might be a solution to cutting the wait, according to researchers from the University of Missouri School of Medicine. Lead author Kristin Sohl and her team partnered with Cognoa, Inc. to test their FDA-approved medical device, CanvasDx, for…
new video loaded: President Trump Reclassifies Marijuana With Executive Order transcript Back transcript President Trump Reclassifies Marijuana With Executive Order Marijuana was downgraded from a Schedule I drug to a Schedule III drug on Thursday. The reclassification does not legalize cannabis, but it does ease restrictions on the substance and allows for more research. Today,…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Happy Thursday. Today, we report on expectations President Trump will unveil more pricing deals with pharma, see new FDA labeling that could affect Pfizer in court, and more. The need-to-know this morning Takeda said its…
Gut microbes may play a key role in training a mother’s immune system to adapt to the developing fetus during pregnancy, according to a preclinical study by Weill Cornell Medicine investigators. The findings, published Dec. 17 in Cell, show that beneficial gut bacteria help prevent immune system reactions that can lead to pregnancy loss in…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Today we look at how RFK Jr. is cementing his power and how his department’s policies are leading some scientists to leave the U.S. The need-to-know this morning Cytokinetics said Chinese regulators…